PLUS1
0.415
-0.015 (-3.49%)
-0.015 (-3.49%)
Upgrade to Real-Time
Market Closed
| Volume | 679,534 |
|
|||||
| News | - | ||||||
| Day High | 0.4525 | Low High |
|||||
| Day Low | 0.41 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CytoDyn Inc (QB) | CYDY | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.015 | -3.49% | 0.415 | 15:59:59 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.4525 | 0.41 | 0.4525 | 0.415 | 0.43 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 281 | 679,534 | $ 0.42481 | $ 288,673 | - | 0.2311 - 2.17 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:59:59 | 322 | $ 0.415 | USD |
Period:
Draw Mode:
CytoDyn Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 337.01M | 812.08M | 556.02M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 39.70M | $ - | - | - | - |
CytoDyn (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYDY Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.48 | 0.619 | 0.362 | 0.4930189 | 2,638,172 | -0.065 | -13.54% |
| 1 Month | 0.4639 | 0.64 | 0.362 | 0.5243234 | 1,352,319 | -0.0489 | -10.54% |
| 3 Months | 0.43 | 1.30 | 0.362 | 0.7342141 | 2,647,644 | -0.015 | -3.49% |
| 6 Months | 0.485 | 1.30 | 0.2311 | 0.5484142 | 2,433,612 | -0.07 | -14.43% |
| 1 Year | 2.14 | 2.17 | 0.2311 | 0.7358831 | 2,558,279 | -1.73 | -80.61% |
| 3 Years | 0.35 | 10.01 | 0.2311 | 2.71 | 3,707,207 | 0.065 | 18.57% |
| 5 Years | 0.60 | 10.01 | 0.0552 | 2.58 | 2,367,696 | -0.185 | -30.83% |
CytoDyn (QB) Description
| CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that is believed to play a role in numerous disease processes. CytoDyn is studying leronlimab in multiple therapeutic areas, including infectious disease, cancer, and autoimmune conditions. |
